Post-Coronavirus Disease 2019 Pandemic Antimicrobial Resistance

  03 March 2024

Antimicrobial resistance (AMR) is a global issue due to improper use of antibiotics. The COVID-19 pandemic has accelerated AMR diffusion, with its clinical and therapeutic features changing. AMR incidence has increased globally, with a varied profile based on germ and microorganism. The increased use of antibiotics and preventive measures during the pandemic led to the spread of resistant microorganisms from low-income countries to the rest of the world. However, there is no clear association between COVID-19 and AMR changes in the post-pandemic period. An integrated, personalized, and regulated use of antibiotics and antimicrobials is needed.

 

Further reading: Antibiotics
Author(s): Lucia Boccabella et al
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed